Source: Annual Congress 2010 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Radzikowska, E. Wiatr, R. Langfort, I. Bestry, P. Rodzinski, A. Jarzebska (Warsaw, Bydgoszcz, Poland). Treatment of pulmonary Langerhans cell histiocytosis with multifocal involvement with vinblastine, prednisolon, mercaptopurine. Eur Respir J 2010; 36: Suppl. 54, 759

Member's Comments

No comment yet.

Related content which might interest you: Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017 Year: 2018 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Multisystemic Langerhans cell histiocytosis unresponsive to aggressive chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 383s Year: 2006 Effectiveness of chemotherapy treatment for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Cladribine improves lung cysts and pulmonary function in a child with histiocytosis Source: Eur Respir J 2015; 45: 831-833 Year: 2015 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Effectiveness of various therapy regimens for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Cladribine as a second line treatment in a child with isolated pulmonary Langerhans cell histiocytosis – case report Source: International Congress 2018 – Orphan diseases in children Year: 2018 Colchicine, prednisone versus no therapy in idiopathic pulmonary fibosis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Granulomatous lung disease in lymphoma patient after rituximab treatment Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma Source: Eur Respir Rev 2009; 19: 86-88 Year: 2010 Rare indications for lung transplantation Source: Eur Respir Mon 2011; 54: 332-340 Year: 2011 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021